The molecular basis of Lmo2-induced T-cell acute lymphoblastic leukemia

Research output: Contribution to journalArticleResearchpeer-review

25 Citations (Scopus)


T-cell acute lymphoblastic leukemia (T-ALL) is commonly caused by the overexpression of oncogenic transcription factors in developing T cells. In a mouse model of one such oncogene, LMO2, the cellular effect is to induce self-renewal of committed T cells in the thymus, which persist long-term while acquiring additional mutations and eventually giving rise to leukemia. These precancerous stem cells (pre-CSC) are intrinsically resistant to radiotherapy, implying that they may be refractory to conventional cancer therapies. However, they depend on an aberrantly expressed stem cell-like self-renewal program for their maintenance, in addition to a specialized thymic microenvironmental niche. Here, we discuss potential approaches for targeting pre-CSCs in T-ALL by using therapies directed at oncogenic transcription factors themselves, downstream self-renewal pathways, and the supportive cell niche. A?2010 AACR.
Original languageEnglish
Pages (from-to)5618 - 5623
Number of pages6
JournalClinical Cancer Research
Issue number23
Publication statusPublished - 2010

Cite this